{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:40:51Z","timestamp":1791438051175,"version":"4.3.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/bmt.2016.352","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T15:27:04Z","timestamp":1484580424000},"page":"717-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Recipient\/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants"],"prefix":"10.1038","volume":"52","author":[{"given":"B E","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N P","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Szydlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W P","family":"Bultitude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Anthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mackinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D I","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pagliuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M N","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N H","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S G E","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"BFbmt2016352_CR1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/blood-2002-09-2866","volume":"102","author":"H Ottinger","year":"2003","unstructured":"Ottinger H, Ferencik S, Beelen D, Lindemann M, Peceny R, Elmaagacli A et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors and HLA-matched unrelated donors. Blood 2003; 102: 1131\u20131137.","journal-title":"Blood"},{"key":"BFbmt2016352_CR2","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","volume":"110","author":"S Lee","year":"2007","unstructured":"Lee S, Klein J, Haagenson M, Baxter-Lowe L, Confer D, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576\u20134583.","journal-title":"Blood"},{"key":"BFbmt2016352_CR3","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1182\/blood-2014-05-576041","volume":"124","author":"J Pidala","year":"2014","unstructured":"Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood 2014; 124: 2596\u20132606.","journal-title":"Blood"},{"key":"BFbmt2016352_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","volume":"13","author":"K Fleischhauer","year":"2012","unstructured":"Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon J-D et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol 2012; 13: 366\u2013374.","journal-title":"Lancet Oncol"},{"key":"BFbmt2016352_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/leu.2009.239","volume":"24","author":"BE Shaw","year":"2010","unstructured":"Shaw BE, Mayor NP, Russell NH, Apperley JF, Clark RE, Cornish J et al. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia 2010; 24: 58\u201365.","journal-title":"Leukemia"},{"key":"BFbmt2016352_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/bmt.2014.8","volume":"49","author":"C Burt","year":"2014","unstructured":"Burt C, Parker A, McQuaker G, Copland M, Brierley C, Little AM et al. In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors. Bone Marrow Transplant 2014; 49: 657\u2013663.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016352_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1182\/blood-2014-10-604785","volume":"125","author":"Y Morishima","year":"2015","unstructured":"Morishima Y, Kashiwase K, Matsuo K, Azuma F, Morishima S, Onizuka M et al. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. Blood 2015; 125: 1189\u20131197.","journal-title":"Blood"},{"key":"BFbmt2016352_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.bbmt.2010.09.012","volume":"17","author":"A Woolfrey","year":"2011","unstructured":"Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 885\u2013892.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016352_CR9","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","volume":"98","author":"C Kollman","year":"2001","unstructured":"Kollman C, Howe C, Anasetti C, Antin J, Davies S, Filipovich A et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043\u20132051.","journal-title":"Blood"},{"key":"BFbmt2016352_CR10","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","volume":"102","author":"P Ljungman","year":"2003","unstructured":"Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C . Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood 2003; 102: 4255\u20134260.","journal-title":"Blood"},{"key":"BFbmt2016352_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cid\/ciu364","volume":"59","author":"P Ljungman","year":"2014","unstructured":"Ljungman P, Brand R, Hoek J, de la Camara R, Cordonnier C, Einsele H et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. Clin Infect Dis 2014; 59: 473\u2013481.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2016352_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/bmt.2011.110","volume":"47","author":"A Gratwohl","year":"2012","unstructured":"Gratwohl A . The EBMT risk score. Bone Marrow Transplant 2012; 47: 749\u2013756.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016352_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"J Fine","year":"1999","unstructured":"Fine J, Gray R . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2016352_CR14","unstructured":"R Core Team. R: A Language and Evnironment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2014. https:\/\/www.r-project.org\/."},{"key":"BFbmt2016352_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2141.2001.02519.x","volume":"112","author":"C Craddock","year":"2001","unstructured":"Craddock C, Szydlo RM, Dazzi F, Olavarria E, Cwynarski K, Yong A et al. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis. Br J Haematol 2001; 112: 228\u2013236.","journal-title":"Br J Haematol"},{"key":"BFbmt2016352_CR16","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/00007890-199505150-00014","volume":"59","author":"A Spencer","year":"1995","unstructured":"Spencer A, Brookes PA, Kaminski E, Hows JM, Szydlo RM, van Rhee F et al. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection. Transplantation 1995; 59: 1302\u20131308.","journal-title":"Transplantation"},{"key":"BFbmt2016352_CR17","first-page":"507","volume":"77","author":"A Bacigalupo","year":"1992","unstructured":"Bacigalupo A, Tedone E, Sanna MA, Moro F, Van Lint MT, Grazi G et al. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality. Haematologica 1992; 77: 507\u2013513.","journal-title":"Haematologica"},{"key":"BFbmt2016352_CR18","doi-asserted-by":"publisher","first-page":"375075","DOI":"10.1155\/2012\/375075","volume":"2012","author":"E Jaskula","year":"2012","unstructured":"Jaskula E, Bochenska J, Kocwin E, Tarnowska A, Lange A . CMV serostatus of donor-recipient pairs influences the risk of CMV infection\/reactivation in HSCT patients. Bone Marrow Res 2012; 2012: 375075.","journal-title":"Bone Marrow Res"},{"key":"BFbmt2016352_CR19","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1182\/blood-2009-02-203307","volume":"113","author":"W Zhou","year":"2009","unstructured":"Zhou W, Longmate J, Lacey SF, Palmer JM, Gallez-Hawkins G, Thao L et al. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. Blood 2009; 113: 6465\u20136476.","journal-title":"Blood"},{"key":"BFbmt2016352_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1086\/591185","volume":"198","author":"H Moins-Teisserenc","year":"2008","unstructured":"Moins-Teisserenc H, Busson M, Scieux C, Bajzik V, Cayuela JM, Clave E et al. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation. J Infect Dis 2008; 198: 818\u2013826.","journal-title":"J Infect Dis"},{"key":"BFbmt2016352_CR21","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/cid\/cir002","volume":"52","author":"FL Pietersma","year":"2011","unstructured":"Pietersma FL, van Dorp S, Minnema MC, Kuball J, Meijer E, Schuurman R et al. Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients. Clin Infect Dis 2011; 52: e144\u2013e148.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2016352_CR22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0140-6736(87)92800-5","volume":"1","author":"JP Grob","year":"1987","unstructured":"Grob JP, Grundy JE, Prentice HG, Griffiths PD, Hoffbrand AV, Hughes MD et al. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections. Lancet 1987; 1: 774\u2013776.","journal-title":"Lancet"},{"key":"BFbmt2016352_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1182\/blood-2014-07-589150","volume":"125","author":"RS Sellar","year":"2015","unstructured":"Sellar RS, Vargas FA, Henry JY, Verfuerth S, Charrot S, Beaton B et al. CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status. Blood 2015; 125: 731\u2013739.","journal-title":"Blood"},{"key":"BFbmt2016352_CR24","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011; 118: 1402\u20131412.","journal-title":"Blood"},{"key":"BFbmt2016352_CR25","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","volume":"122","author":"ML Green","year":"2013","unstructured":"Green ML, Leisenring WM, Xie H, Walter RB, Mielcarek M, Sandmaier BM et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 2013; 122: 1316\u20131324.","journal-title":"Blood"},{"key":"BFbmt2016352_CR26","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/bmt.2013.49","volume":"48","author":"S Ito","year":"2013","unstructured":"Ito S, Pophali P, Co W, Koklanaris EK, Superata J, Fahle GA et al. CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplant 2013; 48: 1313\u20131316.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016352_CR27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/bmt.2016.116","volume":"51","author":"R Admiraal","year":"2016","unstructured":"Admiraal R, Chiesa R, Lindemans CA, Nierkens S, Bierings MB, Versluijs AB et al. Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis. Bone Marrow Transplant. 2016; 51: 1376\u20131378.","journal-title":"Bone Marrow Transplant."},{"key":"BFbmt2016352_CR28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1182\/blood-2011-10-383943","volume":"119","author":"KJ Thomson","year":"2012","unstructured":"Thomson KJ, Mackinnon S, Peggs KS . CMV-specific cellular therapy for acute myeloid leukemia? Blood 2012; 119: 1088\u20131090author reply 90\u20139.","journal-title":"Blood"},{"key":"BFbmt2016352_CR29","doi-asserted-by":"publisher","first-page":"E117","DOI":"10.1002\/ajh.23998","volume":"90","author":"A Busca","year":"2015","unstructured":"Busca A, Passera R, Pini M, Zallio F, Dellacasa C, Audisio E et al. The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors. Am J Hematol 2015; 90: E117\u2013E121.","journal-title":"Am J Hematol"},{"key":"BFbmt2016352_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.bbmt.2014.02.015","volume":"20","author":"J Mariotti","year":"2014","unstructured":"Mariotti J, Maura F, Spina F, Roncari L, Dodero A, Farina L et al. Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2014; 20: 885\u2013890.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016352_CR31","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.bbmt.2014.06.038","volume":"20","author":"F Moscardo","year":"2014","unstructured":"Moscardo F, Sanz J, Carbonell F, Sanz MA, Larrea L, Montesinos P et al. Effect of CD8(+) cell content on umbilical cord blood transplantation in adults with hematological malignancies. Biol Blood Marrow Transplant 2014; 20: 1744\u20131750.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016352_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bmt.1705585","volume":"39","author":"S Ganepola","year":"2007","unstructured":"Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J et al. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39: 293\u2013299.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016352_CR33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bmt.1705825","volume":"40","author":"G Avetisyan","year":"2007","unstructured":"Avetisyan G, Aschan J, Hagglund H, Ringden O, Ljungman P . Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT. Bone Marrow Transplant 2007; 40: 865\u2013869.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016352_CR34","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1182\/blood-2007-06-095265","volume":"110","author":"B Shaw","year":"2007","unstructured":"Shaw B, Gooley T, Malkki M, Madrigal J, Begovich A, Horowitz M et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007; 110: 4560\u20134566.","journal-title":"Blood"},{"key":"BFbmt2016352_CR35","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2010-05-286856","volume":"116","author":"R Chakraverty","year":"2010","unstructured":"Chakraverty R, Orti G, Roughton M, Shen J, Fielding A, Kottaridis P et al. Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. Blood 2010; 116: 3080\u20133088.","journal-title":"Blood"},{"key":"BFbmt2016352_CR36","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/bjh.13239","volume":"168","author":"L Jardine","year":"2015","unstructured":"Jardine L, Publicover A, Bigley V, Hale G, Pearce K, Dickinson A et al. A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants. Br J Haematol 2015; 168: 874\u2013881.","journal-title":"Br J Haematol"},{"key":"BFbmt2016352_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","volume":"127","author":"C Kollman","year":"2016","unstructured":"Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood 2016; 127: 260\u2013267.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016352","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2016.352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:13:21Z","timestamp":1648062801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFbmt2016352"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.352","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]},"assertion":[{"value":"25 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}